These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 20056079)

  • 41. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infusion of dendritic cells carrying donor lymphocytes treated with 8-methoxypsoralen and ultraviolet A light induces CD19+ IL-10+ regulatory B cells and promotes skin allograft survival.
    Wei Y; Zheng D; Li X; Zhou W; Qian Y; Ming C; Shi B
    Transplant Proc; 2014 Dec; 46(10):3641-6. PubMed ID: 25498103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
    Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
    Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Cosmi L; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2007 Aug; 120(2):429-36. PubMed ID: 17604089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4(+)Foxp3(+) Treg cell accumulation.
    Zhang ZX; Lian D; Huang X; Wang S; Sun H; Liu W; Garcia B; Min WP; Jevnikar AM
    Transpl Immunol; 2011 Jan; 24(2):119-26. PubMed ID: 21073952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recipient blood pre-transplant transfusion prolongs hepatic allograft survival in rats.
    Wang FS; Yamaguchi Y; Furuhashi T; Uchino S; Kihara S; Yamada S; Mori K; Ogawa M
    J Surg Res; 2006 Sep; 135(1):52-60. PubMed ID: 16716354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells.
    Xu DL; Liu Y; Tan JM; Li B; Zhong CP; Zhang XH; Wu CQ; Tang XD
    Scand J Immunol; 2004 Jun; 59(6):536-44. PubMed ID: 15182248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in the expression of the immunoglobulin-like transcript 3 (ILT3) and ILT4 receptors in renal allograft recipients: effect of donor and recipient aging.
    Benito MJ; Lopez-Hoyos M; Fernandez-Fresnedo G; Ruiz JC; Benito A; San Segundo D; Gomez-Alamillo C; Arias M
    Transplant Proc; 2008 Nov; 40(9):2894-6. PubMed ID: 19010139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
    Jiang S; Tsang J; Lechler RI
    Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome.
    Daniel V; Naujokat C; Sadeghi M; Weimer R; Renner F; Yildiz S; Opelz G
    Transpl Int; 2008 Jul; 21(7):646-60. PubMed ID: 18298587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion.
    Wang Y; Zhang A; Ye Z; Xie H; Zheng S
    Transplant Proc; 2009 Dec; 41(10):4352-6. PubMed ID: 20005397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats.
    Yang X; Meng S; Jiang H; Zhu C; Wu W
    J Surg Res; 2011 Dec; 171(2):826-32. PubMed ID: 20828738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alloreactive natural killer cells promote haploidentical hematopoietic stem cell transplantation by expansion of recipient-derived CD4(+) CD25(+) regulatory T cells.
    Yu J; Ren X; Yan F; Li H; Cao S; Chen Y; Sun H; An X; Zhang N; Hao X
    Transpl Int; 2011 Feb; 24(2):201-12. PubMed ID: 21062369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble donor-like MHC class I proteins induce CD4(+)CD25(+)CD8(-)FoxP3(+) cells with potential to ameliorate graft chronic injury.
    Andakyan A; Burruss S; Hong LS; Shen XD; Romanov S; Gao F; Feldman DM; Fishbein MC; Semiletova NV
    Transpl Immunol; 2011 May; 24(4):203-9. PubMed ID: 21251981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.